undefined undefined
NaN.000
NaN.00%
An announcement from Allarity Therapeutics, Inc. (ALLR) is now available. Allar...
05-06 21:42
Gainers Eliem Therapeutics (NASDAQ:ELYM) shares moved upwards by 32.8% to $11....
05-04 00:31
Allarity Therapeutics, Inc. (ALLR) has provided an announcement. Allarity Thera...
05-03 18:22
Allarity Therapeutics halts Phase 2 trial, citing compelling early results and plans for regulatory advancement. CEO Thomas Jensen affirms strategic shift. ALLR shares surge 38%.
05-03 00:29
U.S. stocks traded higher this morning, with the Nasdaq Composite surging over ...
05-02 21:52
ALLR: 151% | Allarity Therapeutics shares are trading higher after the company announced that Stenoparib shows a clear clinical benefit, leading to early conclusion of the Phase 2 trial in advanced ovarian
05-02 20:39
An update from Allarity Therapeutics, Inc. (ALLR) is now available. Allarity Th...
04-30 20:23
Allarity Therapeutics (NASDAQ:ALLR) has received a notice which confirms that the Co. has regained compliance with the minimum bid price requirement as set forth in Nasdaq’s Listing Rule. Nasdaq noted...
04-29 21:21
Gainers: Zhongchao (ZCMD) +47%. Neurometrix (NURO) +19%. Mobile health Network Solutions (MNDR) +17%. IMAC Holdings (BACK) +10%. Predictive Oncology (POAI) +10%. Losers: Sunshine Biopharma (SBFM) -39%...
04-19 22:00
Allarity Therapeutics (NASDAQ: ALLR) announced that it had been granted an extension until May 14, 2024, to regain compliance with Nasdaq. Allarity Therapeutics presented a strategic plan to the Nasda...
04-17 21:19